BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35902393)

  • 1. Visceral-to-subcutaneous fat ratio exhibits strongest association with early post-operative outcomes in patients undergoing surgery for advanced rectal cancer.
    Bocca G; Mastoridis S; Yeung T; James DRC; Cunningham C
    Int J Colorectal Dis; 2022 Aug; 37(8):1893-1900. PubMed ID: 35902393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative measures of visceral adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiation.
    Clark W; Siegel EM; Chen YA; Zhao X; Parsons CM; Hernandez JM; Weber J; Thareja S; Choi J; Shibata D
    J Am Coll Surg; 2013 Jun; 216(6):1070-81. PubMed ID: 23523147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher visceral fat area/subcutaneous fat area ratio measured by computed tomography is associated with recurrence and poor survival in patients with mid and low rectal cancers.
    Lee KH; Kang BK; Ahn BK
    Int J Colorectal Dis; 2018 Sep; 33(9):1303-1307. PubMed ID: 29713823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral obesity is associated with outcomes of total mesorectal excision for rectal adenocarcinoma.
    Ballian N; Lubner MG; Munoz A; Harms BA; Heise CP; Foley EF; Kennedy GD
    J Surg Oncol; 2012 Mar; 105(4):365-70. PubMed ID: 21751219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenic Obesity Is a Risk Factor for Worse Oncological Long-Term Outcome in Locally Advanced Rectal Cancer Patients: A Retrospective Single-Center Cohort Study.
    Tschann P; Weigl MP; Clemens P; Szeverinski P; Attenberger C; Kowatsch M; Jäger T; Emmanuel K; Brock T; Königsrainer I
    Nutrients; 2023 Jun; 15(11):. PubMed ID: 37299595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer.
    Choi MH; Oh SN; Lee IK; Oh ST; Won DD
    J Cachexia Sarcopenia Muscle; 2018 Feb; 9(1):53-59. PubMed ID: 28849630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High visceral fat attenuation and long-term mortality in a health check-up population.
    Lee JH; Choi SH; Jung KJ; Goo JM; Yoon SH
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1495-1507. PubMed ID: 37016984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abdominal adipose tissue quantification and distribution with CT: prognostic value for surgical and oncological outcome in patients with rectal cancer.
    Pacquelet B; Morello R; Pelage JP; Eid Y; Lebreton G; Alves A; Fohlen A
    Eur Radiol; 2022 Sep; 32(9):6258-6269. PubMed ID: 35348868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between visceral fat and osteoporotic vertebral compression refractures.
    Zhang P; Lin C; Chen M; He Y; Yan X; Lai J; Fan S; Li S; Teng H
    Nutrition; 2022; 103-104():111808. PubMed ID: 36063722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients.
    Iwase T; Sangai T; Nagashima T; Sakakibara M; Sakakibara J; Hayama S; Ishigami E; Masuda T; Miyazaki M
    Cancer Med; 2016 Jan; 5(1):41-8. PubMed ID: 26626021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High visceral fat with low subcutaneous fat accumulation as a determinant of atherosclerosis in patients with type 2 diabetes.
    Bouchi R; Takeuchi T; Akihisa M; Ohara N; Nakano Y; Nishitani R; Murakami M; Fukuda T; Fujita M; Minami I; Izumiyama H; Hashimoto K; Yoshimoto T; Ogawa Y
    Cardiovasc Diabetol; 2015 Oct; 14():136. PubMed ID: 26445876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semiautomated Measure of Abdominal Adiposity Using Computed Tomography Scan Analysis.
    Srikumar T; Siegel EM; Gu Y; Balagurunathan Y; Garcia AL; Chen YA; Zhou JM; Zhao X; Gillies R; Clark W; Gamenthaler A; Choi J; Shibata D
    J Surg Res; 2019 May; 237():12-21. PubMed ID: 30694786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
    Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
    Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid decline in visceral adipose tissue over 1 month is associated with poor prognosis in patients with unresectable pancreatic cancer.
    Nakano O; Kawai H; Kobayashi T; Kohisa J; Ikarashi S; Hayashi K; Yokoyama J; Terai S
    Cancer Med; 2021 Jul; 10(13):4291-4301. PubMed ID: 33993635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of visceral obesity and sarcobesity on surgical outcomes and recovery after laparoscopic resection for colorectal cancer.
    Pedrazzani C; Conti C; Zamboni GA; Chincarini M; Turri G; Valdegamberi A; Guglielmi A
    Clin Nutr; 2020 Dec; 39(12):3763-3770. PubMed ID: 32336524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of subcutaneous and visceral fat adiposity in patients with colorectal cancer.
    Kim JM; Chung E; Cho ES; Lee JH; Shin SJ; Lee HS; Park EJ; Baik SH; Lee KY; Kang J
    Clin Nutr; 2021 Nov; 40(11):5631-5638. PubMed ID: 34662848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapy.
    Grignol VP; Smith AD; Shlapak D; Zhang X; Del Campo SM; Carson WE
    Surg Oncol; 2015 Dec; 24(4):353-8. PubMed ID: 26690825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial.
    Park HS; Kim HS; Beom SH; Rha SY; Chung HC; Kim JH; Chun YJ; Lee SW; Choe EA; Heo SJ; Noh SH; Hyung WJ; Cheong JH; Kim HI; Son T; Lim JS; Baek SE; Jung M
    Ann Surg Oncol; 2018 Oct; 25(11):3222-3230. PubMed ID: 30051367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Body Composition During Neoadjuvant Chemoradiotherapy on Complications, Survival and Tumor Response in Patients With Locally Advanced Rectal Cancer.
    Liu Z; Lu S; Wang Y; Lin X; Ran P; Zhou X; Fu W; Wang H
    Front Nutr; 2022; 9():796601. PubMed ID: 35155538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.